ANI PHARMACEUTICALS, INC
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $430.6M
Liabilities Breakdown FY2018
Total Liabilities: $233.3M
Asset Breakdown
Total Assets: $430.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $43.0M | 10.0% |
| Accounts Receivable | $64.8M | 15.1% |
| Inventory | $40.5M | 9.4% |
| Property, Plant & Equipment | $38.1M | 8.8% |
| Goodwill | $3.6M | 0.8% |
| Intangible Assets | $201.6M | 46.8% |
| Other Assets | $39.0M | 9.1% |
Liabilities Breakdown
Total Liabilities: $233.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.9M | 3.8% |
| Long-Term Debt | $67.3M | 28.8% |
| Other Liabilities | $157.2M | 67.4% |